MoneyWorks4Me

Fredun Pharmaceuticals’ arm acquires controlling interest in One Pet Stop

30 Jun 2025 Evaluate

Fredun Pharmaceuticals’ (FPL) wholly owned subsidiary -- Fredun Retail (FRPL) has taken a significant step toward expanding its consumer-centric portfolio with the acquisition of a controlling interest in One Pet Stop. This acquisition marks FPL’s formal entry into the organized pet care services market and aligns with its long-term vision of becoming a holistic healthcare provider across human and animal wellness domains. 

With this acquisition, Fredun gains access to a loyal and recurring customer base of over 4,000 pet owners, reflecting One Pet Stop’s established brand equity and trust in the pet care space. One Pet Shop has built a consumer-first business model focused on personalized service, reliability, and convenience. Its user-friendly mobile app allows pet owners to book pet grooming services, track appointments, and receive timely healthcare reminders, thereby fostering long-term customer engagement. 

The acquisition creates strong synergies with Fredun’s Freossi brand, which offers a premium range of pet grooming products. By combining One Pet Stop’s B2C service delivery model with Fredun’s manufacturing capabilities and pan-India distribution network, the Group is poised to expand aggressively across high-consumption zones, particularly within the MMRDA region and other major urban markets. 

Fredun Pharmaceuticals is engaged in manufacturing of pharmaceutical products. 


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..